Goodwin's Life Sciences team supported a biotechnology transaction advancing next-generation CAR-T cancer therapies targeting treatment resistance in hematological and solid tumors.

Goodwin advised Qatalyst Partners, Braze's financial advisor, on the proposed $5.66 billion acquisition by Salesforce for $47.50 per share in cash. Learn more.

Goodwin advised Duvo on its $32 million Series A financing to fund global expansion of its AI-powered enterprise operations platform. Learn more.

Goodwin expands its Microsoft partnership, using Microsoft Foundry and proprietary AI platform Regina OS to transform legal services and enhance client value.

Goodwin advised insitro on its AI-enabled research collaboration with AstraZeneca to discover novel therapeutics for MASH and cardiomyopathies. Learn more.

Goodwin advised Repligen Corporation on its acquisition of BioLife Solutions, expanding its reach in the cell and gene therapy market globally. Learn more.

Goodwin advised General Catalyst in connection with Oratomic’s $775 million in total funding to develop utility-scale, fault-tolerant quantum computers. Learn more.

Recognized for her leadership in European private equity, Anu Balasubramanian earns a place on Financial News’ FN100 Women in Finance 2026 list.

Goodwin advised TRex Bio on IP matters and patent strategy for its $117 million IPO of 8.3 million shares of common stock, priced at $14 per share. Learn more.

Discover Goodwin’s Orange County office in Newport Beach, serving innovators, investors, and market leaders with legal counsel across technology, healthcare, life sciences, private equity, real estate ...

After two years of back-and-forth in the U.S. House of Representatives and Senate, the enacted 2026 NDAA retains a refined version of the BIOSECURE Act, though no longer under that name. (But, for ...